Clinical Decision Support for Familial Hypercholesterolemia
Condition(s) studied
Investigational drug(s) / intervention(s)
Clinical decision support: Computer-based support tool for identification of patients with high levels of total cholesterol or LDL-C, at high risk of being affected by FH.
Study summary
A cluster randomized study in the primary care setting to evaluate a computer-based clinical decision support system to aid in the identification and management of patients with FH. The primary outcome of the study is the number of patients diagnosed with FH thirty-six months after study initiation.
Eligibility
Primary outcome measure(s)
- The number of patients diagnosed with FH (ICD E78.0A) at thirty-six months after study initiation — 36 months after study initiation
The number of probands (index patients) diagnosed with FH (ICD E78.0A) at thirty-six months after study initiation.The diagnosis of FH will be based on the Dutch Lipid Clinic Network (DLCN) criteria. All patients found to have definite or probable FH according to the DLCN criteria will be diagnosed with FH. This endpoint excludes patients diagnosed secondary to cascade screening.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Universitetssjukhuset i Linköping | Linköping | Sweden |
More University Hospital, Linkoeping trials in Sweden
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT03989167 on ClinicalTrials.gov ↗ ← All trials in Sweden